• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION, TAKAHAGI PLANT SUPARTZ FX; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION, TAKAHAGI PLANT SUPARTZ FX; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fatigue (1849); Hyperglycemia (1905); Hypersensitivity/Allergic reaction (1907); Polydipsia (2604); Unspecified Gastrointestinal Problem (4491)
Event Date 09/03/2020
Event Type  Injury  
Event Description
Patient called to report an adverse reaction to supartz fx.Patient stated she use to get euflexxa injections for her osteoarthritis and never had an issue.Patient said due to insurance, she started getting bilateral supartz fx injections on (b)(6) 2020, one week apart for 5 weeks.Patient said within a day or two after receiving her first injection, she had high blood sugar, lower gi issues, fatigue, felt thirsty, and just felt an overall bad feeling.Patient said she was worried she might have to go to the er, but finally her symptoms started to normalize.Patient stated she is an insulin dependent, type 1 diabetic, so it's very worrisome for her.Patient said she was told by her provider that supartz fx was exactly the same as euflexxa, but it's not, it contains an egg or poultry additive which she feels may be triggering her reaction.Patient said she experienced the reaction within a day or two after the injection for the first 3 weeks.Patient said she is due for her 4th injection tomorrow but will not be getting it.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPARTZ FX
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION, TAKAHAGI PLANT
MDR Report Key10579647
MDR Text Key208588564
Report NumberMW5096838
Device Sequence Number1
Product Code MOZ
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 09/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age55 YR
-
-